ASTH Astrana Health, Inc.

Nasdaq Services-Management Consulting Services DE CIK: 0001083446
AI RATING
SELL
72% Confidence

Investment Thesis

Astrana demonstrates strong revenue growth of 56.4% YoY, but faces severe operational challenges with near-zero gross margins (0.1%) and net income declining 51.8% despite scaling revenues—a sign of deteriorating unit economics. High leverage (1.22x D/E) combined with weak interest coverage (1.8x) and profitability margins of just 1.5% create financial vulnerability if operational performance does not substantially improve.

Strengths

  • + Exceptional top-line growth of 56.4% YoY showing strong market demand
  • + Positive free cash flow of $64.1M and solid cash position of $478.4M provides financial cushion
  • + Operating cash flow remains healthy at $68.1M despite net income deterioration

Risks

  • ! Gross margin of 0.1% is critically low and unsustainable; cost structure severely misaligned with revenue
  • ! Net income declining 51.8% while revenue grows 56.4% indicates accelerating margin compression and poor scalability
  • ! Interest coverage ratio of only 1.8x combined with 1.22x debt-to-equity leverage leaves minimal buffer for operational decline

Key Metrics to Watch

Financial Metrics

Revenue
965.1M
Net Income
14.4M
EPS (Diluted)
$0.29
Free Cash Flow
64.1M
Total Assets
2.4B
Cash
478.4M

Profitability Ratios

Gross Margin 0.1%
Operating Margin 3.0%
Net Margin 1.5%
ROE 1.8%
ROA 0.6%
FCF Margin 6.6%

Balance Sheet & Liquidity

Current Ratio
1.35x
Quick Ratio
1.35x
Debt/Equity
1.22x
Debt/Assets
75.5%
Interest Coverage
1.76x
Long-term Debt
979.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-09T09:36:45.921183 | Data as of: 2026-03-31 | Powered by Claude AI